Strongbridge Biopharma plc

SBBP · NASDAQ
Analyze with AI
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Assets
Cash & Equivalents$87,522$57,032$122,490$57,510
Short-Term Investments$0$21,072$0$0
Receivables$2,801$2,289$1,626$1,584
Inventory$1,103$1,993$3,946$511
Other Curr. Assets$926$1,157$4,236$1,208
Total Curr. Assets$92,352$83,543$132,298$60,813
Property Plant & Equip (Net)$813$1,080$294$15
Goodwill$7,256$7,256$7,256$7,256
Intangibles$20,088$25,110$30,132$35,155
Long-Term Investments$0$21,072$0$0
Tax Assets$0$0$0$0
Other NC Assets$591-$20,423$305$686
Total NC Assets$28,748$34,095$37,987$43,112
Other Assets$0$0$0$0
Total Assets$121,100$117,638$170,285$103,925
Liabilities
Payables$1,483$3,331$1,184$1,247
Short-Term Debt$162$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$19,486$20,962$16,065$11,232
Total Curr. Liab.$21,131$24,293$17,249$12,479
LT Debt$17,114$0$0$37,794
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$17,250$21,154$40,081$65,566
Total NC Liab.$34,364$21,154$40,081$103,360
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$55,495$45,447$57,330$115,839
Equity
Pref Stock$0$0$0$0
Common Stock$672$542$541$401
Retained Earnings-$305,558-$260,483-$211,032-$242,883
AOCI$0$0$0$0
Other Equity$370,491$332,132$323,446$230,568
Total Equity$65,605$72,191$112,955-$11,914
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$121,100$117,638$170,285$103,925
Net Debt-$70,246-$57,032-$122,490-$19,716